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Abstract
 
Antigen transport from the airway mucosa to the thoracic lymph nodes (TLNs) was studied in
vivo by intratracheal instillation of fluorescein isothiocyanate (FITC)-conjugated macromole-
 
cules. After instillation, FITC
 
1
 
 cells with stellate morphology were found deep in the TLN T
 
cell area. Using flow cytometry, an FITC signal was exclusively detected in CD11c
 
med-hi
 
/major
histocompatibility complex class II (MHCII)
 
hi
 
 cells, representing migratory airway-derived
lymph node dendritic cells (AW-LNDCs). No FITC signal accumulated in lymphocytes and in
 
a CD11c
 
hi
 
MHCII
 
med
 
 DC group containing a CD8
 
a
 
hi
 
 subset (non–airway-derived [NAW]-
LNDCs). Sorted AW-LNDCs showed long MHCII
 
bright
 
 cytoplasmic processes and intracyto-
plasmatic FITC
 
1
 
 granules. The fraction of FITC
 
1
 
 AW-LNDCs peaked after 24 h and had
reached baseline by day 7. AW-LNDCs were depleted by 7 d of ganciclovir treatment in thy-
midine kinase transgenic mice, resulting in a strong reduction of FITC-macromolecule trans-
port into the TLNs. Compared with intrapulmonary DCs, AW-LNDCs had a mature pheno-
type and upregulated levels of MHCII, B7-2, CD40, and intracellular adhesion molecule
(ICAM)-1. In addition, sorted AW-LNDCs from FITC-ovalbumin (OVA)–instilled animals
strongly presented OVA to OVA-TCR transgenic T cells. These results validate the unique
sentinel role of airway DCs, picking up antigen in the airways and delivering it in an immuno-
genic form to the T cells in the TLNs.
Key words: antigen-presenting cells • endocytosis • ﬂuorescein isothiocyanate • respiratory 
mucosa • lymph nodes
 
Introduction
 
The lungs are extensively exposed to the outside world.
On a daily basis, human lungs process 
 
.
 
10,000 liters of
ambient air. This represents a considerable amount of air-
borne foreign particles which, depending on their size, de-
posit at different levels within the airways. Consequently,
the respiratory system is one of the most immunologically
challenged organs of the body. Therefore, its immunologi-
cal homeostasis must be kept under tight control to provide
adequate defenses while avoiding inappropriate, potentially
life-threatening inflammatory damage.
Dendritic cells (DCs)
 
1
 
 are now widely recognized as
controlling the immune response (1) and a dense network
of DCs has been described in the airway mucosa (2–4).
DCs are the most efficient professional APCs to date and
the only ones capable of eliciting a primary immune re-
sponse. They perform their task through a tightly con-
trolled sequence of events. DC precursors arise in the bone
marrow and home to their target organ. At this stage, they
are in an “immature” state characterized by high Ag uptake
capacity and low expression of surface MHC and T cell co-
stimulatory molecules. Upon contact with Ags, and in the
presence of so-called danger signals (5), DCs evolve to-
wards their mature state; the Ag uptake and processing ma-
chinery is shut down while Ag-loaded MHC and T cell
costimulatory molecules are strongly upregulated on the
cell surface. This is paralleled by a migration of the DCs
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out of the Ag-exposed site into interstitial afferent lymphat-
ics, towards the T cell area of regional LNs (6). Once there,
DCs attract, select, and activate the right Ag-specific naive
T lymphocyte for proliferation and differentiation (7).
Migration is therefore a crucial component of the DC’s
physiology, and hence, of the initiation of an immune re-
sponse. Many cellular functions involved in migration are
differentially regulated in immature versus mature DCs.
These include the response to chemokines (6, 8), the ex-
pression of integrins (9, 10), the downregulation of cad-
herins (11), and the production of tissue-degrading metal-
loproteinases (12). This knowledge is mostly derived from
ex vivo studies involving Langerhans cells (LCs [epidermal
DCs]) and the skin explant model, and may not be relevant
for the airways (13). Our group and others have studied the
migration of DCs in the airways by performing adoptive
transfer of labeled, freshly isolated spleen or bone marrow–
derived DCs into the trachea (14–16). Because of in vitro
enrichment procedures and/or culture in growth factors,
these data may not be representative for the migration of
endogenous DCs residing in the airway mucosa. Con-
versely, functional studies using Ag delivery straight into
the airways did not disclose enough information regarding
the exact phenotype of the migratory, Ag-carrying DCs
and did not visualize the migrating cell types (17).
We addressed these issues by studying the migration of
endogenous airway DCs in vivo based on their ability to
take up and transport fluorescently labeled macromole-
cules. We simultaneously obtained a better insight into the
phenotype and function of these cells.
 
Materials and Methods
 
Animals.
 
Male C57BL/6, DBA/2, and BALB/c mice, 6–8-wk
old, were purchased from Harlan. Heterozygous OVA-TCR
transgenic mice (DO11.10 
 
3
 
 BALB/c) were obtained from Dr.
M. Moser (University of Brussels, Brussels,
 
 
 
Belgium; 18). Thymi-
dine kinase transgenic (TK-TG) mice were a donation from Prof.
D. Klatzmann (Hôpital de la Pitié-Salpêtrière, Paris, France; 19).
For experiments using TK-TG mice, bone marrow chimeric
mice were generated by injecting TK-TG bone marrow cells
into 
 
g
 
-irradiated DBA/2 mice, as described previously (19, 20).
All in vivo manipulations were approved by the local Ethics
Committee.
 
Instillation of Macromolecule Solutions into the Trachea.
 
Fluores-
cein-conjugated macromolecules were diluted in sterile PBS to a
final concentration of 10 mg/ml: FITC-dextran (FITC-DX; mol
wt 40,000, anionic); FITC-OVA (mol wt 45,000; both from
Molecular Probes); mannosylated FITC-BSA; and galactosylated
FITC-BSA (both from Sigma-Aldrich).
For instillation,
 
 
 
mice were anesthetized by intraperitoneal in-
jection of 2.5% avertin, as described previously (15). 70 
 
m
 
l of
macromolecule solution was deposited just above the glottis un-
der sterile conditions using disposable and pyrogen-free 18 GA
polyurethane catheters (Insyte-W; Becton Dickinson), followed
by complete recovery of the animal.
 
Cryostat Sections of Thoracic LNs.
 
Paratracheal and parathymic
LNs were extracted 48 h after intratracheal instillation of fluores-
cein-conjugated Ag. 5-
 
m
 
m cryostat sections were fixed in
acetone and treated with mouse FcR-block followed by RPE-
 
conjugated anti-B220 mAb. The sections were subsequently ex-
amined under fluorescence microscopy.
 
Buffers and Media for Preparation of Single Cell Suspensions and Im-
munofluorescent Labeling.
 
Digestion medium consisted of RPMI
1640, 5% FCS (both from GIBCO BRL), 1 mg/ml collagenase
type 2 (Worthington Biochemical Corp.), and 0.02 mg/ml
DNase I (grade II from bovine pancreas; Boehringer). EDTA-
treated FCS was prepared by passing FCS through a 0.2-
 
m
 
m filter
and mixing 1 ml of a 0.1 M disodium EDTA solution through
every 10 ml of FCS. FACS-EDTA buffer contained PBS without
Ca
 
2
 
1
 
 or Mg
 
2
 
1
 
, 0.1% azide, 5% EDTA-treated FCS, and 5 mM
EDTA. Tissue culture medium (TCM) was prepared using RPMI
1640 supplemented with 5% FCS, penicillin/streptomycin, 
 
L
 
-glu-
tamine, and 2-mercaptoethanol (all from GIBCO BRL).
 
Preparation of Lung and LN Single Cell Suspensions.
 
Animals
were killed and the pulmonary and systemic circulation was per-
fused with saline/EDTA to remove the intravascular pool of
cells. Paratracheal and parathymic intrathoracic LNs were col-
lected. Lungs were carefully separated from thymic and cardio-
vascular remnants and removed in toto, including the main bron-
chi and trachea. Due to the photosensitivity of the FITC
material, organs from FITC-macromolecule–instilled animals
were protected from direct light throughout the manipulation.
Organs were thoroughly minced using iridectomy scissors and
incubated for 30 min in digestion medium in a humidified incu-
bator at 37
 
8
 
C and 5% CO
 
2
 
, according to a modified protocol
(21). Organ fragments were resuspended, fresh digestion medium
was added, and incubation was extended for another 15 min. Af-
ter a final resuspension, very few organ debris were left. Samples
were centrifuged and resuspended in calcium and magnesium–
free PBS containing 10 mM EDTA for 5 min at room tempera-
ture on a shaker. Finally, the cells were subjected to RBC lysis,
washed in FACS-EDTA, passed through a 50-
 
m
 
m cell strainer,
and kept on ice until labeling. Cell viability after this procedure
was consistently 
 
.
 
95%.
 
Labeling of Single Cell Suspensions for Flow Cytometry.
 
mAbs
used to identify mouse DC populations were: biotinylated anti-
CD11c (N418), FITC- and PE-conjugated anti-IA
 
b
 
 (AF6-
120.1), and FITC-IE
 
k
 
 (14-4-4S) (both from BD PharMingen).
Additional markers used for phenotyping were (PE-conjugated
or uncoupled): anti-CD8
 
a
 
 (53-6.7), CD11b/Mac-1
 
a
 
 (M1/70),
CD40 (3/23), CD24/HSA (M1/69), LFA1
 
a
 
/CD11a (2D7),
CD86/B7-2 (GL-1), and hamster anti–CD80/B7-1 (16-10-A1)
(all from BD PharMingen); and rat anti–mouse DEC-205
(NLDC-145) and F4/80 (A3-1) (both from Serotec) and rat anti–
mouse CD54/intracellular adhesion molecule (ICAM)-1 (KAT-1;
Caltag). Isotype controls were RPE-conjugated or uncoupled rat
IgG2a, rat IgG2b, and polyclonal hamster IgG (BD PharMingen).
PE-conjugated goat anti–rat F(ab
 
9
 
)
 
2
 
 fragments (Caltag) were used
as second step reagents.
All staining reactions were performed on ice in FACS-EDTA
buffer. If possible, cells were preincubated with anti-CD16/
CD32 (2.4G2) to reduce nonspecific binding of mAbs. Biotiny-
lated anti-CD11c was revealed by incubation with streptavidin-
PECy5 conjugate (Streptavidin Quantum Red™; Sigma-Aldrich).
Unconjugated rat mAbs were revealed by PE-conjugated goat
anti–rat F(ab
 
9
 
)
 
2
 
 fragments, followed by blocking with normal rat
serum and staining with directly conjugated antibodies. Flow cy-
tometry data acquisition was performed on a FACS Vantage™
flow cytometer running CELLQuest™ software (Becton Dickin-
son). FlowJo software (Treestar) was used for data analysis.
 
Microscopic Examination of Sorted LNDCs.
 
Animals were in-
stilled with FITC-OVA and after 48 h the two clusters of pulmo- 
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nary LN cells appearing in the CD11c
 
1
 
MHC class II (MHCII)
 
1
 
quadrant were sorted on a FACS Vantage™ with a Sort En-
hancement Module (SEM; Becton Dickinson). Cytospin slides
were prepared from each subpopulation and examined under a
fluorescence microscope.
 
In Vitro Pulsing of DCs with Fluorescein-conjugated Ag.
 
Single
cell suspensions from thoracic LN (TLN) digests of several
C57BL/6 mice were pooled. CD11c
 
1
 
 cells were enriched by
layering the cells on a 14.5% metrizamide gradient (Sigma-
Aldrich), as described (15). Cells in the interface were collected,
washed three times, and transferred in triplicate to 96-well plates.
Subsequently, they were pulsed with graded concentrations of
FITC-OVA in TCM and incubated for 30 min on ice or in a hu-
midified incubator at 37
 
8
 
C and 5% CO
 
2
 
. Background fluores-
cence was determined using PBS-pulsed LN cells. After incuba-
tion, cells were labeled with anti-CD11c and anti-MHCII (as
described above). All labeling steps were performed on ice, in the
presence of azide and 5 mM EDTA. FITC mean fluorescence in-
tensity within the CD11c
 
1
 
MHCII
 
1
 
 subpopulations was assessed
by flow cytometry.
 
Ag-specific Proliferation Assay.
 
BALB/c mice were instilled in-
tratracheally with either FITC-OVA or FITC-DX and killed 48 h
later. TLNs were extracted and pooled, and single cell suspensions
were stained with a combination of anti-CD11c and anti-MHCII
(IE
 
k
 
). The two distinct clusters of interest in the CD11c
 
1
 
MHCII
 
1
 
quadrant were sorted on a FACS Vantage™ with SEM. OVA-
specific T cells were isolated from the spleen and LNs of
DO11.10 
 
3 
 
BALB/c mice. After RBC lysis, T lymphocytes were
enriched by magnetic negative depletion of MHCII
 
1
 
, B220
 
1
 
, and
GR-1(RB6)
 
1
 
 cells (Dynabeads; Dynal). Graded concentrations of
CD11c
 
1
 
MHCII
 
1
 
 DCs were added to 2
 
 3 
 
10
 
5
 
 OVA-TCR trans-
genic T cells per well, in triplicate. After 72 h of culture in TCM,
[
 
3
 
H]thymidine (1 
 
m
 
Ci/well) was added to the cultures for the final
12 h. Cell proliferation was measured on an automated liquid
scintillation counter (Microbeta Workstation).
 
Conditional Depletion of DCs.
 
After bone marrow reconstitu-
tion, TK-TG chimeric mice were treated by continuous infusion
of ganciclovir (GCV, Cymevene
 
®
 
; Roche) or vehicle (PBS) us-
ing subcutaneously implanted miniosmotic pumps (ALZET
model 2001; Alza Pharmaceuticals). To selectively eliminate di-
viding myeloid DC precursors, GCV concentration was adjusted
to reach a dose delivery rate of 50–55 mg GCV/kg body wt/d, as
described previously (19, 20). After 7 d, the pumps were ex-
planted and 1 d was allowed for any residual drug to wash out.
Subsequently, mice were instilled with FITC-OVA and 48 h
later TLNs were processed and labeled as described above.
 
Results and Discussion
 
Ag Transport from the Airways to the TLNs.
 
TLN cryo-
stat sections obtained 48 h after intratracheal instillation of
FITC-DX or FITC-OVA showed numerous FITC
 
1
 
 cells
that were strictly confined to B220
 
2
 
 T cell zones (Fig. 1
A). A closer look revealed stellar-shaped collections of
FITC material reaching deep into the LN paracortex (Fig.
1 B). Based on the stellate morphology and localization
within the T cell area, we hypothesized that DCs within
the draining LNs contained FITC
 
1
 
 material 48 h after in-
stillation of FITC-labeled macromolecules into the trachea.
To address this further, TLNs of FITC-OVA–instilled
mice were subjected to collagenase/DNase/EDTA treat-
ment. The use of enzymatic stromal digestion, Ca
 
2
 
1
 
-free
media, and EDTA has been documented to favor the isola-
tion of as many DCs from lymphoid organs as possible by
extracting tightly tissue-bound DC subsets and disrupting
DC–lymphocyte rosettes (22). TLN cell suspensions were
stained using the DC marker combination MHCII plus
CD11c (
 
a
 
x 
 
chain of the p150,95 integrin abundant on mu-
Figure 1. TLN cryostat section from a DX-FITC–instilled mouse, as seen under fluorescence microscopy. (A) Staining with the B cell marker B220
(red): FITC1 cells are confined to the B cell–negative, paracortical T cell–dependent zones. (B) High power magnification of the paracortical zone show-
ing numerous infiltrating FITC1 cells with a stellate morphology. 
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rine DCs) and examined by flow cytometry, as described in
earlier studies (23). The cells were analyzed on bivariate
plots of MHCII versus CD11c and examined for FITC
positivity (Fig. 2 A). Dead cells and debris were excluded
based on light scatter properties. Two main clusters of cells
could be distinguished in the MHCII
 
1
 
CD11c
 
1
 
 quadrant.
One group of cells (group 1) had a very strong expression
of MHCII and intermediate to high levels of CD11c
(MHCII
 
hi
 
CD11c
 
med-hi
 
), while group 2 had intermediate
expression of MHCII and high level expression of CD11c
(MHCII
 
med
 
CD11c
 
hi
 
). As seen in Fig. 2 B, 24 h after instil-
lation of FITC-OVA into the airways of mice, FITC posi-
tivity was exclusively detected in group 1 LNDCs. At that
particular time point, the FITC signal was absent in group
2 LNDCs as well as in cells in the CD11c
 
2
 
 lymphocyte
gate (not shown on this density plot as these cells comprise
 
z
 
95% of the whole LN cell population).
To further confirm that MHCII
 
hi
 
CD11c
 
med-hi
 
 cells were
indeed DCs containing FITC, cytospin preparations of
sorted group 1 LNDCs were examined using fluorescence
microscopy (Fig. 3, A and B). FITC material appears in
yellow-green, whereas MHCII stains red (anti-IA
 
b
 
–RPE).
Group 1 LNDCs showed a typical DC morphology with
long MHCII 
 
bright
 
 cytoplasmic extensions (Fig. 3 A) and
FITC material concentrated in intracytoplasmic granules
 
(none on the cell surface; Fig. 3 B). No FITC signal was
visible in group 2 LNDCs (data not shown).
To check whether FITC positivity in the LNs may be
due to passive leakage of fluorescein-conjugated macromol-
ecules from the airway mucosa to the draining TLNs, we
assessed the capacity of both LNDC populations described
above to take up FITC-OVA in vitro (Fig. 4). Both groups
were equally capable of taking up FITC-OVA in a dose-
dependent manner. For instance, pulsing the cells with 0.1
mg/ml FITC-OVA resulted in 86.5 
 
6 
 
0.1% and 84.0 
 
6
 
1.9% FITC
 
1
 
 cells in group 1 versus group 2 LNDCs. This
uptake was partially inhibited by cold, which hints to an ac-
tive endocytic process. The capacity of group 2 LNDCs to
take up Ags in vitro was in sharp contrast to the in vivo sit-
uation, in which virtually no FITC signal was seen in these
cells after intratracheal instillation of FITC-OVA (Fig. 2 B,
bottom). We could therefore exclude the possibility of an
important passive leakage of free FITC-OVA from the air-
way mucosa to the draining LNs, at least in baseline condi-
tions and with healthy animals. In fact, macromolecules
such as albumins or dextrans are commonly used in physio-
logical studies to test the integrity of endothelial and epithe-
lial barriers, including the respiratory epithelium (24, 25).
Based on the presence of FITC
 
1
 
 granular material within
group 1 (MHCII
 
hi
 
CD11c
 
med-hi
 
) LNDCs and the exclusion
Figure 2. (A) Flow cytometric staining pattern of TLN
single cell suspensions, labeled with rat anti–mouse
MHCII (PE) and hamster anti–mouse CD11c (PE-Cy5).
Two clusters were invariably distinguished in the
CD11c1MHCII1 quadrant. (B) The animals were given
an intratracheal instillation of a 10 mg/ml FITC-OVA so-
lution (gray histogram) or PBS as a control (white histo-
gram). After 24 h, only group 1 LNDCs acquired a strong
FITC signal.
Figure 3. Morphology of
sorted group 1 (MHCIIhi
CD11cmed-hi) LNDCs 24 h after
intratracheal instillation of DX-
FITC, as seen under fluores-
cence microscopy. The cells,
sometimes appearing in clusters
(B), have numerous MHCII1
(bright red) cytoplasmic pro-
cesses (A), kidney-shaped nu-
clei, and granular concentrations
of FITC-bright material inside
the cytoplasm.55 Vermaelen et al.
of passive leakage of FITC1 material into the draining
TLNs, we believe that these cells have taken up Ags and
migrated from the airways, thus representing airway-derived
(AW)-LNDCs, whereas group 2 (MHCIImedCD11chi) cells
are non–airway-derived (NAW)-LNDCs.
Interestingly, transport of macromolecular Ags by AW-
LNDCs appears to be selective. FITC-OVA and FITC-DX
were comparable in their ability to be carried to the TLNs
(Fig. 5). To verify the possible involvement of the mannose
receptor (MR) in this process, we instilled mannosylated
FITC-BSA and used galactosylated FITC-BSA as a control
neoglycoconjugate which does not bind to the MR. Sur-
prisingly, in vivo Ag uptake was low in both cases. This is
in sharp contrast to human cultured DCs (26), but in accor-
dance with recent reports demonstrating the absence of the
MR on murine DCs in situ (27). Therefore, other MR-like
receptors could be involved in the macromolecule uptake
we observed. Although DEC-205, a lectin-like receptor
shown to be involved in Ag processing by DCs (28), is ex-
pressed on murine pulmonary DCs (29; and our observa-
tion below), no glycosylated ligands for DEC-205 have yet
been uncovered. Another possible candidate is Langerin, a
recently described DC-specific C-type lectin receptor ex-
pressed on human DCs (including those within bronchial
epithelium [30, 31]) and murine DCs (data not shown).
Kinetics of Ag Transport by AW-LNDCs. Having con-
firmed the nature of migratory AW-LNDCs, a kinetics ex-
periment was conducted (Fig. 6) and showed FITC-carry-
ing AW-LNDCs appearing in the TLNs as soon as 6 h after
the instillation of FITC-OVA, with a peak influx reached
at 24 h. Similar migration rates were found in our previous
studies using intratracheal instillation of carboxy fluorescein
succinimidyl ester (CFSE)-labeled exogenous DCs in mice
(15), in which we found CFSE1 DCs appearing in the LNs
as soon as 12 h after injection. In addition, experiments us-
ing intratracheal delivery of soluble protein Ag describe an
appearance of strong Ag-presenting activity in DCs of
draining LNs 24 h after instillation (17). The kinetics of
migration are also in agreement with the early occurrence
of T cell activation and proliferation in Ag-specific TCR
transgenic T cells when peptide- or Ag-pulsed DCs are de-
posited in the airways. In these models, some T cells have
already proliferated three times 48 h after injection of Ags
into the trachea (7). This rapid migration of DCs seems to
occur in the absence of airway inflammation and is a funda-
mental feature of DCs at mucosal interfaces, not observed
in skin LCs (32).
A considerable fraction of cells in the AW-LNDC clus-
ter did not acquire Ags after instillation. This could indicate
that macromolecules instilled intratracheally do not reach
DCs in all lung compartments. Alternatively, FITC2 AW-
LNDCs could either not be derived from peripheral immi-
grating DCs (an origin among myeloid resident LNDCs
populations has been suggested in the case of skin LC–
derived LNDCs [23]) or they could be derived from a
subset of lung DCs with a low trafficking rate. Indeed,
considerable heterogeneity exists in the turnover rate (and
functions) of different pulmonary DC subsets (32–34).
Similarly, using TK-TG mice, 7 d of selective myeloid DC
precursor depletion resulted in a partial elimination of AW-
LNDCs from the TLNs (Table I). This indicates that a sub-
stantial fraction of AW-LNDCs has a transit time (from di-
viding precursor through lung to LNs) longer than 1 wk.
In contrast, a similar 1-wk conditional DC depletion in a
previous study resulted in .95% disappearance of MHCII1
Figure 4. In vitro uptake of FITC-OVA by group 1 (A) and group 2
(B) LNDCs. Filled and open symbols represent uptake at 378C and 48C,
respectively. Values are mean fractions of FITC1 cells 6SE derived from
triplicate experiments. Both LNDC subgroups are equally capable of tak-
ing up FITC-OVA in vitro.
Figure 5. Comparison of different fluorescein-conjugated macromole-
cules in their ability to be transported within AW-LNDCs. Bar heights
represent mean percentage of FITC1 AW-LNDCs 6SE. Notice low
uptake of mannosylated FITC-BSA compared with FITC-DX on
FITC-OVA.56 Antigen Transport by Pulmonary Dendritic Cells
DCs from the tracheal epithelium (20). In the present pa-
per, the partial (37%) depletion of AW-LNDCs is accom-
panied by a drastic (86%) reduction in FITC-OVA trans-
port (Fig. 7). Taken together, these data suggest that the
majority of FITC-OVA–carrying DCs were derived from
airway intraepithelial DCs. The remaining unaffected
FITC1 AW-LNDCs could represent Ag-carrying DCs
with a lower turnover rate.
In our migration kinetics studies, the aim was to come as
near as possible to the description of the steady state flux.
DCs are exquisitely sensitive to specific environmental
stimuli and maturation/migration can be triggered by very
low dose endotoxin, mechanical stress, or damage in sur-
rounding tissue (5). The following precautions were taken
to avoid these triggers as much as possible: (a) disposable
sterile and pyrogen-free instillation catheters were used; (b)
there was no actual penetration of the catheter tip inside
the trachea; (c) random testing for endotoxin contamina-
tion was performed on the instillates and found to be nega-
tive; and (d) low toxicity/high stability of succinimidyl es-
ters of FITC-macromolecules were chosen as opposed to
isothiocyanate esters, and free dye was removed through
dialysis. Nevertheless, it can be argued that the aspiration of
the macromolecule solution, however inert, could repre-
sent a local stress signal in itself.
Still, the trafficking rate we observe is of similar magni-
tude as previously described estimates of DC turnover after
irradiation (32). This supports the idea that the FITC-con-
jugates instilled in our model are relatively inert “tell-tales”
for tracking the movement of airway DCs.
Very early after instillation, some FITC signal was ob-
served within resident LNDCs. However, at most 6% of
these LNDCs became FITC1 (12 h after instillation) and,
in contrast to FITC1 AW-LNDCs, these cells did not fur-
ther accumulate beyond that early time point, reinforcing
the notion that NAW-LNDCs do not import Ag deposited
in the periphery.
As far as the disappearance of FITC1 AW-LNDCs from
the TLNs is concerned, studies will be necessary to deter-
mine which DC apoptosis/survival-related factors are
mainly involved. This is a significant issue, as preliminary
data point towards an altered clearance of Ag-carrying
AW-LNDCs in a model of allergic airway inflammation.
Phenotype of Lung and Mediastinal LNDCs. We com-
pared the phenotype of lung and TLN DCs after collage-
nase digestion and EDTA treatment of whole lungs and
corresponding TLNs. We chose to phenotype cells right
after organ digestion in order to avoid artefacts originating
from additional DC enrichment and culture procedures.
AW and NAW DC subsets in the LNs were outlined using
the MHCII/CD11c double staining as described above. To
pinpoint DCs in the lungs, we used a strategy based on
findings by Havenith et al. (35) in which DCs and mono-
cytic DC precursors were identified within the low auto-
fluorescent cell fraction of rat bronchoalveolar lavage fluid.
Additionally, in this study the phenotype of the low auto-
fluorescent cell fraction was found to shift further towards
typical mature DC morphology after overnight incubation.
We applied this approach to murine lung cells and added
the expression of CD11c to the immunofluorescent identi-
fication criteria (Fig. 8 A). Two peaks of autofluorescence
could be distinguished within the CD11c1 gate. When
sorted, CD11c1/low autofluorescence cells showed a pre-
dominant monocyte and immature DC morphology. After
overnight incubation in cytokine-free, serum-supple-
mented medium this appearance shifted clearly towards
typical DCs with numerous cytoplasmic extensions (data
not shown). We did not consider high levels of surface
MHCII as a DC identification criterion a priori in order to
Figure 6. Kinetics of DC entry into TLNs. Groups of mice were
killed at several time intervals after intratracheal instillation of a 1%
FITC-OVA solution. The fraction of FITC1 cells was determined
within AW- (d) and NAW- (s) LNDCs (formerly group 1 and group 2
LNDCs, respectively). Each time point is derived from four to seven
mice and represents the mean percentage of fluorescein-positive LNDCs
6SE, subtracting background autofluorescence obtained from PBS-
instilled mice (dotted line).
Figure 7. Treatment of TK-TG
bone marrow chimeras with sys-
temic (sys) GCV: impact on FITC-
OVA transport within AW-LNDCs.
Bars represent mean fraction of
FITC1 AW-LNDCs 6SE. The de-
pletion in absolute number of AW-
LNDCs was taken into account
when calculating the percentage of
FITC1 cells in the GCV-treated
group.
Table I. Reduction in the Absolute Number of AW-LNDCs
and NAW-LNDCs after a 1-wk Systemic GCV Treatment in 
HSV1-TK Transgenic Bone Marrow Chimeras
PBS-sys GCV-sys  Reduction
%
AW-LNDC 45,887 6 4,985 28,854 6 10,920 37
NAW-LNDC 3,322 6 646 2,314 6 613 30
Values are mean 6 SE, n 5 6 mice per group. PBS-sys, systemic vehicle
treatment; GCV-sys, systemic GCV.57 Vermaelen et al.
avoid a bias towards more mature forms. Nevertheless,
CD11c1/low autofluorescence cells were .90% MHCII1.
Therefore, these cells are hereafter referred to as “intrapul-
monary DCs.” The mean fluorescence intensity of MHCII
was even higher for CD11c1 TLN cells (Fig. 8 B).
Fig. 9 shows a surface phenotypic comparison between
pulmonary DCs and corresponding TLN DC subsets.
Compared with their intrapulmonary counterpart, AW-
LNDCs were clearly more mature as illustrated by an up-
regulation of MHCII (Fig. 8) and the T cell costimulatory
molecules CD40, B7-2, and ICAM-1 (Fig. 9 B). This spe-
cific pattern of phenotypical shift is also seen after in vitro
maturation induction of cultured DCs by such various fac-
tors as mechanical stress, LPS, necrotic cells, and a variety
of other danger signals (5). Our observations suggest that
even in the absence of specific danger signals or Ag, lung
DCs undergo phenotypical maturation as they migrate to
the TLNs.
Interestingly, we were unable to detect any significant
levels of B7-1 on either murine pulm-DCs or AW-
LNDCs. In contrast, this costimulatory molecule was
clearly detected in a previous work performed on murine
pulmonary DCs, albeit at weaker levels than B7-2 (36). In
this study however, the DCs were further enriched by an
overnight adherence step, which could alter the pheno-
type. Using the same antibodies, we have previously re-
ported that both B7-1 and -2 are very strongly expressed
on cultured bone marrow DCs, illustrating that the absence
of B7-1 might be typical of freshly isolated lung DCs (16).
Another noteworthy difference between intrapulmonary
DCs and AW-LNDCs was the consistent low level expres-
sion of CD8a on the latter cells (Fig. 9 A). In contrast,
both cell types expressed the Mac-1 myelomonocytic
marker as well as DEC-205 (traditionally observed on LCs,
DCs derived from bone marrow culture [37] and thymic
DCs [38]). Although DCs seeding nonlymphoid peripheral
organs are generally considered to be of myeloid origin,
there have been reports of CD8a expression on LCs as
they arrive into cutaneous LNs (39, 40). It was also shown
that in vitro CD40 ligation induces expression of CD8a on
purified LCs (41). The fact that CD8a was absent from
lung DCs, but clearly expressed on AW-LNDCs, also sug-
gests a similar mechanism.
In contrast to the CD8alowDEC-205high migratory
LNDCs, the main feature of NAW- LNDCs was a high
level expression of both DEC-205 and CD8a. The NAW-
LNDC cluster was heterogeneous, however, as it also con-
tained cells expressing the myeloid marker Mac-1. This is
Figure 8. (A) Identification of DCs in collage-
nase digests of whole lungs (parenchymal tissue and
large airways including trachea, no bronchoalveolar
lavage) after collagenase/DNase/EDTA treatment.
Pulmonary DCs, defined as CD11c1/low autofluo-
rescence cells, were found to be MHCII1, in con-
trast to CD11c1/high autofluorescence cells. (B)
CD11c1 TLN cells obtained using the same organ
digestion protocol show even higher MHCII ex-
pression.
Figure 9. Phenotypic comparison between DCs identified in whole lung digests (pulm-DC defined as CD11c1/low autofluorescence; see Fig. 8 A)
and DC subsets within TLNs (see Fig. 2 A). Cells were phenotyped right after organ digest, without any additional enrichment procedure. Semitranspar-
ent histograms, isotype controls; gray histograms, Ag-specific antibodies. (A) Lineage markers. (B) T cell costimulatory molecules/maturation markers.
Compared with pulm-DCs, AW-LNDCs have upregulated levels of CD40, B7-2, and ICAM-1 (framed markers) and upregulate low levels of CD8a as
well (arrow, A). Note the strong expression of CD8a on NAW-LNDCs.58 Antigen Transport by Pulmonary Dendritic Cells
analogous to findings reported by Salomon et al. (23) in
which three subpopulations of DCs were described in cuta-
neous LNs, only one of which (MHCIIhiCD11cmed-hi) be-
came FITC1 after skin painting with FITC. The exact ori-
gin of NAW-LNDC subsets and their possible relationship
to AW-LNDCs need further investigation.
AW-LNDCs Efficiently Present Ag Deposited in the Air-
ways. It was necessary to verify the functional impact of
the findings outlined above, namely that AW-LNDC
transport Ag from the airways to the TLNs and phenotypi-
cally mature while doing so. Therefore, we conducted
an in vitro antigen-specific proliferation assay using AW-
LNDCs from FITC-OVA–instilled BALB/c mice as
APCs, and DO11.10 T cells as OVA-responsive cells. As
can be seen in Fig. 10, after FITC-OVA instillation AW-
LNDCs induced a very strong OVA-specific T cell prolif-
eration, again stressing the unique role of these cells in the
uptake and processing of Ag deposited in the airways. In
this setting, FITC2 NAW-LNDCs also induced some T
cell proliferation, albeit several orders of magnitude weaker
than when AW-LNDCs were used as APCs. The possibil-
ity of nonspecific T cell stimulation could be ruled out, as
AW-LNDCs from FITC-DX–instilled animals induced no
T cell proliferation in the same culture conditions. Several
explanations exist for the low level induction of T cell pro-
liferation by NAW-LNDCs. (a) Some contamination of
NAW-LNDCs by AW-LNDCs may have occurred during
fluorescence-activated cell sorting. (b) Alternatively, the
minor early uptake of FITC1 material in NAW-LNDCs
(see kinetics) could suffice to load these cells with very low
levels of Ags, generating a low ligand density and a subopti-
mal T cell response. (c) Another possibility is the transfer of
Ag between AW- and NAW-LNDCs. In previous work
by Inaba et al. (42, 43), it was shown that Ags from incom-
ing migratory DCs and apoptotic cells can be efficiently
presented on (possibly CD8a1) DCs residing in the T cell
areas. It is possible in our model that NAW-LNDCs (con-
taining a CD8a1DEC-2051 subset) have phagocytosed and
processed apoptotic AW-LNDCs, including their OVA
cargo. Alternatively, recent experiments also suggest that
preformed MHC–peptide fragments can be transferred
from one DC to another (44, 45).
In summary, we have described the kinetics of pulmo-
nary DC migration from the airways to the T cell zones of
the TLNs by relying on their Ag-carrying properties. This
migration is accompanied by phenotypic maturation and
very efficient presentation of the peripherally administered
soluble Ag. The novel approach we used allows the study
of the kinetics of DC-mediated Ag transport in pathologi-
cal states such as allergic airway inflammation. In addition,
it offers the possibility of investigating the relative contri-
bution of chemokines, cytokines, metalloproteinases, and
integrins and cadherins to the migration of airway DCs, by
means of pharmacological blockade and the use of knock-
out or transgenic animals.
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